No Image Available

Sodium Bicarbonate Enteric Coated Tablet Generics

Form: Tablet

Strength: 325mg, 650mg, 1000mg

Reference Brands: Oracit® (US), Bicarbonate sandoz (EU)

Category: Nephrology

Sodium Bicarbonate Enteric-Coated Tablets are widely used in nephrology to manage metabolic acidosis in patients with chronic kidney disease (CKD). These tablets help restore the body’s acid-base balance by neutralizing excess acid, supporting kidney function and slowing disease progression. The enteric coating ensures targeted intestinal release, minimizing gastric irritation and improving patient tolerance. Marketed under brands like Neut®, Bicitra®, and Sodium Bicarbonate EC Tablets, they are trusted by nephrologists globally. Ideal for B2B pharmaceutical importers and distributors, we offer high-quality Sodium Bicarbonate Tablets for bulk export, meeting international regulatory standards for renal care and chronic disease management.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Calcitriol Generics

Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL

Form: Capsules & Injection

Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)

View Details Get Enquiry
Paricalcitol Generics

Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL

Form: Capsules and Injection

Reference Brands: Zemplar®(US &EU)

View Details Get Enquiry
Calcifediol(Ref.Brand: Rayaldee®(US) Generics

Strength: 30 mcg

Form: ER Oral Capsule

Reference Brands:

View Details Get Enquiry
Methoxy Polyethylene Glycol-Epoetin Beta Generics

Strength: 25–250 mcg

Form: Solution for Injection

Reference Brands: Mircera® (US &EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience on our website. Learn more